The American Academy of Orthopaedic Surgeons (AAOS), along with JAAOS (aka the “Yellow Journal”), the AAOS Resident Assembly and OrthoMentor have come together to create this forum in order to further the mentorship and education of orthopaedic surgeons during various stages in their career. Authors from the contributing organizations will offer insights into residency transitions, medical school success, attending involvement and more.
Learn More: https://soundsfromthetrainingroom.com/
Faculty draw on material based on common test questions to guide you through the vast amount of content for each specialty area. This focused approach includes dedicated time for high-yield review sessions to re-cap the most important testable facts and concepts.
This blended learning program is the premier course with exclusive pre- and post-event resources with online access to study resources to build your conﬁdence at your own pace. Start preparing early - access to the pre-course content on an exclusive registrant portal will be available in January 2020.
S.2849, vetoed on December 23rd, would have created a list of safeguards designed to protect patients with private, commercial health insurance plans seeking to remove drugs from their pharmacy benefit formularies, in the middle of a contract year. New York’s current law puts thousands of patients at risk of losing access to therapies for such chronic and life-threatening diseases as epilepsy, rheumatoid arthritis, multiple sclerosis, among many others. It also usurps decisions by physicians as to what the most effective therapy is to treat a patient’s condition. NYSSOS was in support of the passage of the bill.
The Governor vetoed the bill because of concerns that “Insurers would have to anticipate and set rates for hypothetical future drug price increases, causing higher premiums for everyone, while pharmaceutical companies would be able to raise their prices with impunity”.
On December 26, the Governor vetoed, S.6531, which would have increased the oversight, transparency and accountability of Pharmacy Benefit Managers (PBMS). According to a recent article published by MSSNY, the Governor vetoed the bill because of concerns that provisions could be pre-empted by ERISA, and invite scrutiny from the FTC and DOJ and “sweep in plans that are not true PBMs, but rather health benefit funds only.”
The NYS Workers’ Compensation Board has a number of resources to help medical providers understand and utilize the NY Workers’ Compensation Drug Formulary.
• Overview Video: Providers are encouraged to watch the Board’s video for medical providers, which includes a detailed overview, examples, and screenshots of the new drug formulary and the associated processes.
• Drug Formulary Web Page: Providers can also visit the Drug Formulary Overview page for information about the NY WC Formulary, a PDF of current and previous versions, details on the prior authorization process, frequently asked questions, and quick links to additional resources.
• New! January 13th Live Webinar Q&A Session: The Board is hosting a follow-up Q&A webinar so you can get answers to any remaining questions you may have. To make the most of this time, please be sure to watch the video and review the website information ahead of this session.
January 13, 2019
2:00 p.m. - 3:00 p.m.
If you would like to send your questions in advance of the session, or if you have an urgent question, please write to email@example.com.
My Glimpse into the World of Advocacy
Matthew Conti, MD
I didn’t know there is an underground subway connecting the House of Representatives and Senate buildings to the U.S. Capitol until I was running through the halls with Representative Virginia Foxx (R-N.C.). We jumped into the “members only” elevator, sprinted to the subway, and arrived just in time for a vote on the House floor. I also didn’t know there is an orthopaedic surgeon who is also a senator until I met John Barrasso, MD, FAAOS (R-Wyo.). I also didn’t know the difference between the terms “regulatory” and “legislative” until I did the AAOS Resident Advocacy Fellowship.
NYSSOS congratulates Dr. Conti on his advocacy efforts and for getting involved at the State level. We look forward to his participation on the State level as well!
> Read the full story
Over the past year, I have spent time meeting with and learning from the AAOS Office of Government Relations (OGR), located in Washington, D.C. Truthfully, before I applied for the fellowship, I didn’t even know that the office existed. Based on a recent poll undertaken during my AAOS Instagram stories takeover, about 70 percent of respondents said they did not know that AAOS has an office in Washington, D.C.
I have learned that effecting change in government requires persistence and patience. Ironically, one of the reasons I went into orthopaedics was that the care we provide has more immediate results. If a bone is broken, it needs to be urgently fixed. But if the government is broken, then we form a committee to debate the merits of fixing it, vote on a resolution, and then have a debate on the House floor.
Change does happen though—very slowly. We are fortunate as a profession to have dedicated, passionate people in Washington, D.C., fighting battles daily on behalf of orthopaedic surgeons—battles most of us do not even know about. While you’re preparing for your first total knee arthroplasty of the day, the AAOS advocacy team is fighting to make sure that case isn’t delayed because you couldn’t get timely prior authorization from the insurance company.
I’ve learned a tremendous amount over the past year. Prior to the AAOS Resident Advocacy Fellowship, I didn’t know that the voice of an orthopaedic surgeon in Congress is powerful, or how important it is to donate to the Orthopaedic Political Action Committee.
Matthew Conti, MD, is an AAOS 2019 Resident Advocacy Fellow and is completing postgraduate year-4 at the Hospital for Special Surgery
Read his full story: https://www5.aaos.org/aaosnow/2019/dec/advocacy/advocacy01/
Joanne Willer, Manager of coding and reimbursement resources in the AAOS Office of Government Relations, recently wrote an article for the AAOS Now summarizing the relevant changes to the musculoskeletal section for 2020.
To view her full article follow this link.
Below is a overview of her article. For a full summary of the additions, deletions, and revisions, refer to Appendix B of the CPT Manual.
Six new add-on codes describing insertion and removal of drug-delivery implant devices specific to musculoskeletal treatments have been added to the CPT code set for 2020.
The new codes were created to differentiate between the existing codes (which are in the integumentary section of CPT 11981–11983) and orthopaedic procedures for the treatment of soft tissue-, bone-, and joint-related infections. The new codes are for insertion, removal, and removal with reinsertion of nonbiodegradable drug-delivery implants.
Multiple specialties have been using the existing codes, which lack specificity, and that was the catalyst for change.
CPT code 20926, Tissue grafts, other (e.g., paratenon, fat, dermis), has been deleted for 2020.
That code was identified as potentially misvalued by the AMA Relative Value Scale Update Committee Relativity Assessment Workgroup (RAW). RAW determined that the code was being used for significantly different procedures, such as small soft-tissue grafts, correction of minor contour deformities, and placement into a defect for reconstructive purposes.
In the absence of code 20926, five new codes have been created to report those services.
Additionally, several changes were made to codes within the Extracranial Nerves, Peripheral Nerves, and Autonomic Nervous System section of the CPT Manual, including revised code descriptors to the 64400–64450 series of codes; instructional parenthetical notes; and deletion of codes 64402, 64410, and 64413.
The New York Workers’ Compensation Board Drug Formulary (NY WC Formulary) becomes effective on December 5, 2019 for all new prescriptions.
All new prescriptions for injured workers in New York State must be listed within the NY WC Formulary unless an alternative medication has been approved through the NYS Workers’ Compensation Board’s new prior authorization process.
The new electronic prior authorization process will soon be available through the Board’s Medical Portal; please watch for the notification.
Please visit the Board’s Drug Formulary Overview webpage for:
Information and resources related to requesting prior authorization through the Board’s Medical Portal, can be found on the Board’s Medical Portal Overview webpage.
For more information or assistance: http://www.wcb.ny.gov/content/main/hcpp/DrugFormulary/overview.jsp
The NYS WC Board is hosting webinars to provide training on the Drug Formulary and prescription prior authorization process. Visit the Board's website to register: http://www.wcb.ny.gov/webinars/
October 22, 8:30 a.m. - 9:30 a.m.
October 24, 4:30 p.m. - 5:30 p.m.
October 29, 8:30 a.m. - 9:30 a.m.
For more information, visit wcb.ny.gov/content/ebiz/drugformulary/
General Formulary questions: WCBFormularyQuestions@wcb.ny.gov
Technical support questions: WCBCustomerSupport@wcb.ny.gov
Changes to National Government Services Local Coverage Determination Process
In accordance with Section 4009 of H.R. 34-21st Century Cures Act (Public Law No: 114-255), CMS is updating the “Medicare Program Integrity Manual” with detailed changes to the LCD process.
NYSSOS serves the interests of New York orthopaedists and their patients by helping to create an optimal practice environment in which to provide quality and efficacious orthopaedic care.
Address: PO Box 38004, Albany, NY 12203